Sotera Health beats Q1 estimates, shares rise on strong outlook

Published 01/05/2025, 16:38
Sotera Health beats Q1 estimates, shares rise on strong outlook

Investing.com -- Sotera Health Company (NASDAQ:SHC) reported first-quarter 2025 results that surpassed analyst expectations, sending its shares up 4.6% in trading. The global provider of sterilization solutions and lab testing services posted adjusted earnings per share of $0.14, beating the consensus estimate of $0.12, while revenue of $255 million topped expectations of $245.13 million.

The company’s net revenues increased 2.6% YoY to $255 million, or 4.4% on a constant currency basis. Adjusted EBITDA rose 8.8% to $122 million compared to the same quarter last year, representing an 11.2% increase on a constant currency basis.

Despite reporting a net loss of $13 million or -$0.05 per diluted share, which included a $31 million settlement related to ethylene oxide claims, Sotera Health’s adjusted figures showed improvement. The company reaffirmed its full-year 2025 outlook, projecting net revenue growth of 4.0% to 6.0% and adjusted EBITDA growth of 4.5% to 6.5%, both on a constant currency basis.

Chairman and CEO Michael B. Petras, Jr. commented, "We are pleased to report a solid start to the year with mid-single digit revenue growth and strong double digit Adjusted EBITDA growth, on a constant currency basis."

The company’s Sterigenics segment saw a 1.9% increase in net revenues to $170 million, while Nordion reported a significant 35.6% jump to $33 million. However, Nelson Labs experienced a 9.3% decline to $52 million.

Sotera Health maintains its full-year 2025 adjusted EPS guidance of $0.70 to $0.76, in line with the analyst consensus of $0.74.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.